Figure 1
Individual dose-normalized pomalidomide concentration vs time profiles: healthy normal participants vs patients with MM3.
Figure 1 | Leukemia
Individual dose-normalized pomalidomide concentration vs time profiles: healthy normal participants vs patients with MM3.
